banner2

Getting started
Methyl 4-Aminobutanoate Hydrochloride

Methyl 4-Aminobutanoate Hydrochloride - China Manufacturers, Suppliers, Factory

Methyl 4-Aminobutanoate Hydrochloride, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Xylazine Hydrochloride CAS 23076-35-9 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Xylazine Hydrochloride CAS 23076-35-9 Assay 98.0%-102.0% High Purity
Read More

Azetidine Hydrochloride CAS 36520-39-5 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Azetidine Hydrochloride CAS 36520-39-5 Assay ≥98.0% (HPLC)

cis-4-Hydroxy-D-Proline Hydrochloride CAS 77449-94-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — cis-4-Hydroxy-D-Proline Hydrochloride CAS 77449-94-6 Assay ≥98.0% (HPLC)

Glycine Ethyl Ester Hydrochloride CAS 623-33-6 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Glycine Ethyl Ester Hydrochloride CAS 623-33-6 Purity ≥99.0% (HPLC)

β-Alanine tert-Butyl Ester Hydrochloride CAS 58620-93-2 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — β-Alanine tert-Butyl Ester Hydrochloride CAS 58620-93-2 Assay ≥98.0% (HPLC)

3-Chloro-D-Alanine Methyl Ester Hydrochloride CAS 112346-82-4 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 3-Chloro-D-Alanine Methyl Ester Hydrochloride CAS 112346-82-4 Assay ≥98.0% (HPLC)

L-(-)-Histidinol Dihydrochloride CAS 1596-64-1 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — L-(-)-Histidinol Dihydrochloride CAS 1596-64-1 Assay ≥98.0% (HPLC)

banner4

Top Selling Products

Related Blog
Reviews

Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...

2022.12.12 02:20:37
2022.11.01 07:50:47
2022.07.20 22:43:07
2022.07.09 23:52:19
2022.06.11 13:13:41
2021.10.29 08:30:15

related search